MX2018002983A - Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación. - Google Patents
Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación.Info
- Publication number
- MX2018002983A MX2018002983A MX2018002983A MX2018002983A MX2018002983A MX 2018002983 A MX2018002983 A MX 2018002983A MX 2018002983 A MX2018002983 A MX 2018002983A MX 2018002983 A MX2018002983 A MX 2018002983A MX 2018002983 A MX2018002983 A MX 2018002983A
- Authority
- MX
- Mexico
- Prior art keywords
- fibres
- preparation
- treatment
- suspension
- antiviral
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 5
- 239000000725 suspension Substances 0.000 title abstract 3
- 230000002708 enhancing effect Effects 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/30—Copper compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/32—Tin compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/28—Zirconium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
La presente invención consiste en una suspensión antiviral para tratamiento de fibras que comprende por lo menos una sal orgánica de un metal mono, di o trivalente con actividad antiviral suspendida en una solución reguladora del pH ácido; el proceso para obtenerla; y el proceso para obtener fibras antivirales empleando dicha suspensión antiviral.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2018002983A MX2018002983A (es) | 2018-03-09 | 2018-03-09 | Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación. |
| PCT/MX2018/000034 WO2019172739A1 (es) | 2018-03-09 | 2018-04-09 | Suspensión antiviral potencializadora para tratamiento de fibras y su método de preparación |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2018002983A MX2018002983A (es) | 2018-03-09 | 2018-03-09 | Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018002983A true MX2018002983A (es) | 2019-09-10 |
Family
ID=67847349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018002983A MX2018002983A (es) | 2018-03-09 | 2018-03-09 | Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación. |
Country Status (2)
| Country | Link |
|---|---|
| MX (1) | MX2018002983A (es) |
| WO (1) | WO2019172739A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117684393A (zh) * | 2023-10-19 | 2024-03-12 | 浙江金海高科股份有限公司 | 一种具有抗病毒性能的干用纤维材料及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6475526B1 (en) * | 2001-06-05 | 2002-11-05 | Jeffrey B. Smith | Zinc containing compositions for anti-viral use |
| DE102005020327A1 (de) * | 2005-04-30 | 2006-11-09 | Multibind Biotec Gmbh | Dekontaminationslösungen und deren Verwendung zur Denaturierung, Modifikation, Degradation, Solubilisierung und Entfernung von Proteinen, Nukleinsäuremolekülen und Mikroorganismen von Oberflächen |
| DE102006058790A1 (de) * | 2006-12-12 | 2008-06-19 | Sanitized Ag | Verfahren zur antimikrobiellen Ausrüstung von Textilien und Faser |
| DE102007030103A1 (de) * | 2007-06-28 | 2009-01-02 | Bode Chemie Gmbh & Co. Kg | Verwendung einer synergistischen Zusammensetzung als therapeutisches oder kosmetisches Mittel |
| DE102008064481A1 (de) * | 2008-12-18 | 2010-08-12 | Bode Chemie Gmbh | Kombinierte Desinfektions- und Dekontaminationsmittel mit erhöhter Wirksamkeit |
| MA41021A (fr) * | 2014-11-25 | 2017-10-03 | Cms Tech Inc | Compositions antimicrobiennes à base de cuivre et leur utilisation dans le traitement de produits alimentaires et de surfaces |
| RU2743529C1 (ru) * | 2015-09-29 | 2021-02-19 | Текуро Медикал Гмбх | Стабилизированные антисептические препараты |
-
2018
- 2018-03-09 MX MX2018002983A patent/MX2018002983A/es unknown
- 2018-04-09 WO PCT/MX2018/000034 patent/WO2019172739A1/es not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019172739A1 (es) | 2019-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX357216B (es) | Postratamiento de un material zeolitico. | |
| PH12018500664A1 (en) | Anti-lag3 antibodies and uses thereof | |
| CL2015003355A1 (es) | Derivados del bipirazol como inhibidores jak | |
| MY192888A (en) | Dna alkylating agents | |
| PH12019501425A1 (en) | Human antibodies to s. aureus hemolysin a toxin | |
| WO2016100261A3 (en) | Method of treating cancer with cgamp or cgasmp | |
| TN2014000058A1 (en) | A Novel 1,2,3,4-Tetrahydroquinoline Derivative Useful for the Treatment of Diabetes | |
| MX2017007816A (es) | Proceso para mejorar porciones y productos musculares. | |
| SG11201811835YA (en) | Diorganylphosphinic acid salts, method for the production thereof and the use thereof | |
| NZ704092A (en) | Ph adjusted pulse protein product | |
| EA201890884A1 (ru) | Способ и композиции для нежелательных и аномальных мышечных сокращений | |
| NZ702178A (en) | Lingo-2 antagonists for treatment of conditions involving motor neurons | |
| EP3487985C0 (en) | METHOD FOR PREVENTING OR TREATING MOVEMENT DISORDERS USING LACTIC BACTERIA | |
| PH12014502193B1 (en) | Multiple uses of amine salts for industrial water treatment | |
| WO2020209988A3 (en) | Diverse marker panel for ptsd diagnosis and treatment | |
| PH12017502069A1 (en) | Method for treating coffee rust, citrus black spot, citrus scab and banana black sigatoka diseases | |
| MX2022001703A (es) | Metodos para producir estiercol tratado. | |
| PH12022550486B1 (en) | Pathogenic control compositions and methods | |
| MX2018002983A (es) | Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación. | |
| EP4397752A3 (en) | Methods for obtaining induced smooth muscle cells | |
| PH12017500998A1 (en) | Treatment of ocular conditions using progenitor cells | |
| MA43069A (fr) | Procédé pour lutter contre des mauvaises herbes résistantes ou tolérantes aux herbicides | |
| SG11201803868RA (en) | Hydroponic culture method for plant in high salinity environment | |
| EP3522827A4 (en) | DEVICES AND METHODS FOR TREATING CONGESTIVE HEART FAILURE, ASCITES, AND OTHER DISORDERS RELATED TO EXCESS BODY FLUID | |
| PH12020551455A1 (en) | Method for controlling harmful insects |